Accutest Laboratory Ltd, one of the fastest growing laboratory of India, has received their second USFDA approval for its Bioequivalence projects of Fluconazole Tablet 200mg Tablets. The project was submitted as a part of ANDA submission for JB Chemicals and Pharmaceuticals Ltd.

Untill now, the Accutest Laboratory have submitted 12 Bio projects to USFDA as a part of ANDA submission for its various clients. On the other hand, another four projects are nearing completion and will be submitted very soon.

Apart from USFDA Approval, Accutest have received recognition from Drug Controller General (DCGI), ANVISA (Brazil), Regulatory Body of Zimbabwe (MCAZ), MCC (South Africa).